Financial And Administrative Dysfunctions Will Slow Growth Of Pharmaceutical Sales In Tunisia
Pharmaceuticals / Tunisia / Mon 05 Dec, 2022
Key View
- Pharmaceutical manufacturing disruptions and a deteriorating fiscal position will pose headwinds to pharmaceutical sales in Tunisia.
- Pfizer will be the fourth pharmaceutical multinational to cease operations in Tunisia recently.
- Drug shortages in Tunisia will increase in frequency and severity.
Pharmaceutical manufacturing